Therapeutic effect of octreotide combined with continuous hemofiltration in patients with severe acute pancreatitis complicated with acute respiratory distress syndrome
Li MA,Tian FU,Chengli WANG,Mingsen HE,Xueli WANG
DOI: https://doi.org/10.3969/j.issn.1671-6450.2018.01.012
2018-01-01
Abstract:Objective To investigate the clinical efficacy of octreotide combined with continuous hemofiltration in patients with severe acute pancreatitis complicated with acute respiratory distress syndrome.Methods Selected 100 patients with severe acute pancreatitis complicated with acute respiratory distress syndrome from October 2010 to May 2017,they were randomly divided into observation group and control group,each group with 50 cases,the control group of patients with conventional continuous hemofiltration therapy,observation group of patients also with octreotide intravenous infusion treatment.Observe the two groups before and after treatment's levels of PaO2,PaO2/FiO2 and APACHE Ⅱ.Results The levels of serum amylase,serum calcium,endotoxin,ALT,BUN,CRP,HR,RR,oxygenation index,APACHE Ⅱ score,SIRS score and IL-1,IL-6,TNF-α were decreased.There was no significant difference in cytokines (P ＞ 0.05).Compared with before treatment,the levels of serum amylase,endotoxin,ALT,BUN,CRP,HR and RR were significantly decreased in the two groups after treatment,and the serum calcium content was significantly increased(P ＜ 0.01).After treatment,PaO2,PaCO2 and PaO2/FiO2 values of the two groups were significantly higher than those of the control group(P ＜ 0.01),and the difference was significant(P ＜0.01).After treatment,the APACHE Ⅱ score and SIRS score of the two groups were significantly decreased(P ＜ 0.01),and the improvement of the control group was significantly better than that of the control group (P ＜ 0.01).Conclusion Octreotide combined with continuous hemofiltration can effectively remove the inflammatory mediators in the blood and improve the clinical symptoms and prognosis.